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Abstract 
Objective: Recurrence is a difficult stage in the cancer journey as it brings to the fore the life 
threatening nature of the illness. This meta-ethnography examines and synthesises the 
findings of qualitative research regarding patients’ experience of cancer recurrence.  
Methods: A systematic search of the qualitative studies published between 1994 and April 
2014 was undertaken. Seventeen relevant papers were identified and a meta-ethnography 
conducted.  
Results:  Six third-order concepts were developed to capture patients’ experiences: 
Experiencing emotional turmoil following diagnosis, which described the emotional impact 
of diagnosis and the influence of previous experiences on how the news were received; 
Experiencing otherness, encompassing changed relationships; Seeking support in the health 
care system, describing the extent of information needs and the importance of the relationship 
with health care professionals; Adjusting to a new prognosis and uncertain future, 
highlighting the changes associated with uncertainty; Finding strategies to deal with 
recurrence, describing ways of maintaining emotional well-being and regaining a sense of 
control over cancer; and Facing mortality, describing the difficulties in facing death-related 
concerns and associated  consequences.   
Conclusions:  This meta-ethnography clarifies the fundamental aspects of patients’ 
experience of recurrence.  It suggests that health care professionals can promote a positive 
experience of care and help lessen the psychosocial impact of recurrence by providing 
information in an approachable way, listening to patients and being sensitive to their 
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changing needs and concerns. It also points to the importance of supporting patients in 
adopting strategies to regain a sense of control and to address their potential mortality and its 
impact on loved ones.   
3 
 
 
Background 
In 2011, over 331 000 people were diagnosed with cancer in the UK [1]. Unless cancer is 
already advanced at the time of diagnosis, patients are usually offered surgery, chemotherapy 
or radiotherapy or a combination of these. If after a period of being disease free, cancer 
comes back, it is defined as a recurrence [2]. Despite improvement in initial cancer 
treatments, recurrence is still relatively common [e.g 3 4 5].Though the risk varies across 
cancer types, and by stage, grade and other tumour characteristics, improvements in 
treatments mean many more people will live for longer with active and advanced disease [6].  
Recurrence is a difficult stage in the cancer journey. It challenges patients’ hopes that cancer 
can be cured, emphasises the life threatening nature of the illness [7-10] and highlights 
uncertainty about the future [11-13].  
Qualitative research and qualitative syntheses have been increasingly recognised as filling an 
important gap in providing an understanding of patient experience to inform policy [14]. 
Meta-ethnography is one of the interpretative methods available to bring together evidence 
from qualitative research. Although it originated in the area of education [15], interest in 
meta-ethnography has been extended and further developed in the field of heath care 
research[16]. It has been suggested  that meta-ethnography is most suitable when looking at 
individuals’ experiences [17]. The meta-ethnography presented in this paper followed the 
approach developed by Noblit and Hare [15] further developed by Toye and [18 19] and was 
conducted to explore, evaluate and synthesise the existing knowledge base regarding patients’ 
experiences of a recurrence of cancer.     
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Methods 
Noblit and Hare [20] identified seven stages (Figure 1), which constitute the iterative process 
of meta-ethnography [18].  
 
 
 
 
 
Stage one involved an initial scoping review of research on the experience of cancer which 
identified the experience of cancer recurrence as appropriate for a meta-ethnography.   
Systematic search and critical appraisal 
Stage two comprised defining the scope and terms of the search strategy and critically 
appraising the studies identified. 
Due to well-known difficulties of indexing qualitative studies, particular attention was paid to 
developing a comprehensive search strategy for studies which used a qualitative 
methodology.  As the last two decades have seen major changes in cancer treatments and 
health care services, it was decided to restrict the search to this period.  Three electronic 
databases – Medline, CINAHL and Psychinfo – were searched for studies published between 
January 1994 and April 2014, using the search terms listed in Table 2.  The grey literature 
was not searched.  The criteria for inclusion in the meta-ethnography were that the study: a) 
Figure 1 1 Seven stages of Noblit and Hare’s meta ethnography 
1. Getting started 
2. Deciding what is relevant to the initial interest 
3. Reading the studies 
4. Determining how the studies are related 
5. Translating the studies into one another 
6. Synthesising translations 
7. Expressing the synthesis 
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explored the experience of patients with a cancer recurrence b) used qualitative methodology 
to gather and analyse results and c) were published in English.   
[Insert Table 1] 
 While a number of tools are used in appraising qualitative studies, the Critical Appraisal 
Skills Programme (CASP) Qualitative Research Checklist is most commonly used in meta-
ethnography [21]. All studies included in this review were appraised using the CASP tool and 
then coded using the coding scheme devised by Dixon-Woods: KP (key paper providing rich 
conceptual insights), SAT (satisfactory paper), FF (fatally flawed) and IRR (irrelevant: not 
meeting inclusion criteria) [22]. All papers were reviewed by one reviewer (Anonymous) and 
by one of two additional reviewers (Anonymous). Quality appraisal was conducted to gather 
information about the quality of the current evidence. It was decided not to exclude any 
papers based on quality as methodologically weak papers can still provide rich conceptual 
insights [23].   
Data extraction and Synthesis 
Stage 3 involved reading the articles selected for the synthesis and re-reading for further 
familiarisation. As part of this process, relevant information including background, methods 
and results were extracted.  
Stage 4 focused on determining how the studies were related. As part of this process, first 
order constructs (quotes from the participants) and second order constructs (key concepts and 
themes and their interpretation by the paper’s authors) were extracted by MW and one of MB 
or EW independently. Second-order constructs form data for meta-ethnography and the 
purpose of extracting first order constructs is only to provide illustrative quotes. As Toye et al 
[18] have pointed out quotes provided under a particular second-order constructs are selected 
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by authors and therefore may not illuminate all aspects of it. To aid this process, a table was 
created, with each second-order construct from each paper listed alongside the representative 
quotes from the participants [16]. Each row represented one second order construct from a 
particular paper.  
Stage 5, reciprocal translation of the studies, involved looking at how studies were related to 
each other and required reading each row, comparing across studies, to consider how the 
constructs were related.  The focus here was on the descriptions of the second order 
constructs rather on the terms used.  
Stage 6, synthesising translations, involved generating third-order constructs. For example, 
the second order construct diagnosis of recurrence in the study by Mahon and Casperson [9] 
and emotional reactions in Griffiths et al. [24] each contributed to the third order-construct 
experiencing emotional turmoil after diagnosis. An illustration of the process is presented in 
Table 1. The aim here was not only to summarise the data but to create conceptually rich 
third-order constructs, encompassing the dynamic experience of participants. This synthesis 
took form of a reciprocal translation, which is possible when studies included describe similar 
findings [15].  
 [Insert Table 1]
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Results of the search 
The search yielded 2271 articles after duplicates were removed. One reviewer (Anonymous) 
screened each abstract and two additional reviewers (Anonymous) screened a subset (10%) to 
establish if the paper was 1) a qualitative paper and 2) addressed the topic of interest. This 
initial screen resulted in 2150 articles being rejected. The remaining 121 were subjected to 
full text review and 103 were excluded for a number of reasons. Figure 2 summarises the 
screening process.   
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Figure 2.  PRISMA flowchart 
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database searching: 
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(n=  ) 
Records after duplicates removed: 2271 
 
(n=  ) 
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(abstract and title) 
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(n=  ) 
Records excluded 
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(n=  ) 
Full-text articles 
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eligibility: 121 
 
(n=  ) 
Full-text articles excluded, 
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32 did not use qualitative 
methodology 
49 did not include, or clarify 
that they included, patients 
with a recurrence of cancer  
13 did not allow extraction of 
data relevant to patients with 
a recurrence  
3 did not focus on patients 
2 evaluated interventions 
4 could not be obtained 
1 did not contribute to the 
meta-ethnography (IRR) 
Articles included in 
qualitative 
synthesis: N=17 
 
(n=  ) 
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A total of 17 articles were included, based on 15 data sets. Studies were published between 
1997 and 2014 and were conducted in UK, Europe (Sweden) and North America (Canada 
and USA). They included patients with a range of cancer types, with breast and ovarian 
cancer most common. The main method of data collection was individual interview but a 
variety of analytical approaches were used, including Phenomenology, Grounded Theory and 
Content Analysis.   Chunlestkul et al. [25-27] conducted one study, which resulted in two 
publications [25-27] and Ekwall et al [7,27] conducted one study which resulted in two initial 
publications and, following further interviews with a sub-group of the initial sample three and 
five years later, they published a third paper [28].  Table 3 provides a description of all the 
studies included in the meta-ethnography. 
[Insert Table 3] 
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Critical appraisal: 
Papers differed in the extent to which they met the quality criteria. All papers clearly stated 
aims and the rationale for choosing a qualitative methodology. However, some described 
their chosen methodology in greater detail and displayed a more critical approach to their 
findings.  Few explicitly considered the way the researchers’ assumptions may have shaped 
the findings and in some papers, the analytical approach used was not made explicit.  Studies 
also differed in the extent to which they provided rich conceptual insights.  Seven were coded 
as a key paper, and 10 as of satisfactory quality. No papers were rated as fatally flawed. 
Results 
The synthesis identified wide-ranging ways in which a cancer recurrence impacted on 
participants. The third-order constructs developed to capture these were: Experiencing 
emotional turmoil following diagnosis, Experiencing otherness, Seeking support in the health 
care system, Adjusting to a new prognosis and uncertain future, Finding strategies to deal 
with recurrence; and Facing mortality.  
1. Experiencing emotional turmoil following diagnosis  
Diagnosis of recurrence was a distressing emotional experience for the majority of patients, 
generating a range of responses including shock, fear, anger, devastation or hopelessness [7 9 
10 23 31]. In two studies of patients with a recurrence of oral cancer and ovarian cancer, 
participants described feelings of shame and guilt for developing cancer again [7 23].  
With two exceptions [10 32], the studies found that awareness of the possibility of recurrence 
did not lessen the emotional impact [9 10 31 32]. As one participant said: “I knew all along it 
could come back but let me tell you, nothing could ever prepare you for it” [9 p.183 ].  While 
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experiencing symptoms facilitated detection of the recurrence for some[7 8 10 28 29], others 
initially attributed the symptoms to non-cancer causes [9 28 30]. For those who did not 
experience any symptoms and were diagnosed on the basis of a change in a tumour marker, 
the experience was particularly shocking [7 30].  
2. Experiencing otherness 
Recurrence of cancer had wide-ranging social impacts and challenged existing relationships 
between patients and those close to them. These challenges related to expressing feelings as 
well as managing changing bodies. Growing closer and sharing the burden of cancer was also 
part of the experience for some patients.  
2.1 Experiencing difficulties in sharing the uncomfortable with others  
Sharing emotional as well as physical suffering with family members was found to be 
challenging [7 28 29].Negotiating  disclosure of the diagnosis as well as receiving support in 
making decisions regarding treatment were also described as difficult by some patients [29 31 
32]. Inability to express feelings and concerns about triggering negative reactions in people 
could result in patients withdrawing from work or leisure activities and some studios 
highlighted that this made the experience for patients a lonely one [10 32 33]. The fear that 
they were becoming a burden and contributing to the family’s suffering also hindered patients 
in sharing their distress [10 26 32].  
Sharing feelings and preparations related to mortality and death was also challenging for 
some patients [26 32]. Chunlestskul and colleagues [26] and Vilhauer [32], in describing the 
experiences of women with metastatic breast cancer, highlighted their sense of being silenced 
from discussing their mortality as it made people feel uncomfortable and generated 
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superstitious fears about bringing on death. Other patients felt that by discussing death, they 
could be perceived as having lost their “fighting spirit” [25 32].  
While they rarely mentioned to clinicians their difficulties in discussing mortality [25], 
patients valued the opportunity to discuss their death-related concerns with counsellors and 
support groups [26]. At the same time, maintaining normality and not always being treated as 
an ill person was also welcomed by some participants [29 32]. The balance between being 
able to talk about their experience and trying to live a normal life was difficult to achieve, 
however, as families could sometimes be overprotective [29 32].  
2.2 Managing their social lives with a changing body 
Feelings of otherness were also generated by bodily changes as a result of treatment. A loss 
of physical ability and ongoing symptoms caused a number of patients to reduce their daily 
activity and had an impact on their quality of life [7 24 29 30 33]. Accepting these physical 
limitations was often difficult, as it meant increased dependence on other people and losing 
previous roles, though support from family could facilitate adjustment to these changes [29]. 
An altered body image caused distress and affected individuals’ well-being and their 
relationships with others. Side effects and changes to bodies following breast cancer 
treatment were perceived as disfiguring and difficult to accept [7 10 32]. Some felt that their 
altered bodies were a visible sign of dying and as such, triggered uncomfortable reactions 
from others [10 28 32 33]. For patients with oral cancer, the consequences of further 
treatment could affect their ability to communicate, which made them feel isolated [34].  
Becoming frustrated with pain could also negatively impact on family dynamics [29]. These 
changes lead some people to withdraw from social activities [32], while some needed time to 
adjust to bodily changes before returning to previous social lives [34]. Those in intimate 
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relationships experienced changes to sexual life [7 11] while those wanting to form 
relationships perceived it as a barrier [32].  
A diagnosis of recurrence also seemed to create a number of changes to the daily rhythms of 
participants’ lives, which had to be negotiated within the context of their social relationships. 
Patients decisions on whether or not to undertake activities were often influenced by 
fluctuating periods of deterioration and recovery, which families sometimes struggled to  
adjust to [33]. The need for support also depended on the illness cycle, which other people 
sometimes found difficult to understand [32]. Relentless treatment regimens meant the loss of 
capable bodies and demanded constant adjustment. This often resulted in careful monitoring 
of their bodies and sensitivity to changes  [33]. 
2.3 Connecting and growing with people 
For some, a recurrence of cancer resulted in positive changes to relationships. Being able to 
share death-related concerns was appreciated and facilitated growth and feelings of closeness 
with families and other cancer patients [25 26].  An awareness of the fragility of life and 
facing one’s mortality could also contribute to a greater appreciation of family and friends [7 
27 35]. Social and practical support from family as well as other cancer patients lessened the 
distress, gave them strength to carry on [8 34] and helped in accepting and living with the 
limitations of the illness [8 29 34 35].  
3. Seeking support in the health care system 
Interaction with health care professionals when re-entering the system following the news of 
recurrence was an important part of patients’ experience. Seeking and negotiating medical 
information and Wanting to be known and valued by clinicians were important components 
of that interaction.  
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3.1 Seeking and negotiating medical information  
Information provision and communication were integral to patients’ experience of recurrence.  
Dealing with information about prognosis was a complex process carefully negotiated 
between patients and clinicians. Both patients and clinicians searched for clues on how to talk 
about prognosis [36]. This was well described by Step and Ray as the “prognosis dance”, as 
illustrated by the following participant: “She wanted to tell me as little as possible to get me 
through to the next step and I pushed a bit” [36 p.54]. The amount of information wanted and 
needed by patients varied. Some wanted greater recurrence-specific information, including 
prognosis, treatment options, reasons for recurrence and risks of further recurrences [7 31 36 
37] and carefully sought the required information [36], while others found this level of 
information overwhelming[8 29]. Information provision could lessen anxiety and facilitate 
understanding of the situation. Although the clinical team was seen as the main source of 
information, some also wanted, but did not always get, access to other cancer patients with a 
recurrence to share information and experience [8 31]. Some participants also described the 
need to be more proactive in order to obtain the information they wanted regarding treatment 
and prognosis [30].Terminology related to cancer recurrence was also found to be confusing 
for patients, especially when compared with information provided at the initial diagnosis. 
This often left them to interpret things on their own [36]. In contrast, two studies described 
how information at the initial diagnosis facilitated their understanding of the situation at 
times of recurrence [8 9].  
 
3.2 Wanting to be known and valued by clinicians  
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The nature of the relationship was also found to be an important factor contributing to either 
positive or negative experiences of health care at the time of recurrence. Having information 
provided in an approachable and sensitive way, being listened to and being offered help were 
facilitators of positive experiences of care [29 35 37]. Being seen as a partner to a health care 
professional and sharing responsibility of care with them was also seen as important [37]. 
Continuity of care was valued as it facilitated not only the diagnosis but also more effective 
and trusting relationships [8]. Conversely, feelings of being rushed, insensitive 
communication, use of jargon, lack of communication between staff and broken promises 
were inhibitors of positive experiences of care[27 35 37].  For example, Howell and 
colleagues found that patients with a recurrence of ovarian cancer often perceived that 
clinicians’ attitudes had changed and felt that they had given up on them [30].  
4. Adjusting to an uncertain future and a new prognosis 
Following the diagnosis, worry about further disease progression was common [32 34 35] 
and participants often balanced awareness of the possibility of death with hope for more time. 
Progression of disease usually signified fewer treatment options and transition from cure to 
controlling active disease or symptoms [8 30 35 36]. As a participants with ovarian cancer 
recurrence noted: “I didn’t feel that I had any options, because she presented two things to 
me and they were dependant on the state on my health” [8]. Those who were able to have 
surgery perceived it as a better option than systemic therapy [9 34 35], regardless of the lack 
of guarantees for cure [35]. Although longing for a break, patients continued with treatment 
in the hope of prolonging their lives [29 33]. The uncertainty around prognosis and changing 
treatment regimens could also be overwhelming for patients [37] and prevented them from 
having long-terms plans, which they found difficult. 
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Some studies highlighted that the diagnosis of a recurrence signified for patients the need to 
become familiar with a new disease and its implications [8 9 10].  Previous experiences of 
cancer could have an impact on how current experience was understood [9]. The diagnosis of 
a recurrence often brought a realisation that a cure may no longer be possible and that death 
was now a real possibility This was often in contrast to how they viewed their prognosis after 
initial diagnosis, which was more positive [8 10]. Equally, having experience of a previous 
recurrence reinforced for some the belief that  remission was once more possible [9]. 
5. Finding strategies to deal with recurrence 
5.1 Attempting to regain control over cancer  
In the context of uncertainty, attempting to take control over cancer was important for 
patients. Taking responsibility for one’s own health by eating well or exercising was 
perceived as facilitating recovery following treatment and maximising the chances of survival 
[7]. Adopting a fighting spirit and positive attitude were also seen as ways to aid recovery 
and halt disease progression [7 29 35]. Seeking second opinion and asking for a specific 
treatment or alternative therapies was an important part of this process. [28 30 37]. In one 
study of patients with metastatic cancers who were experiencing pain, patients did not always 
adhere to their medication as prescribed, as they felt they knew when medication was needed 
and chose to stop or reduce activities to control pain [31].  
 
5.2 Taking steps to preserve emotional well-being  
Taking steps to preserve emotional well-being in the context of the threat of death was an 
important way of dealing with the impact of cancer recurrence and studies described a variety 
of ways on which patients attempted to do so, including activities which restored emotional 
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balance [25] and leaving a legacy in the form of life projects [26]. Giving up activities which 
were found to evoke stress, such as employment, was taken as a conscious decision by some, 
and aided the preservation of emotional resources [32 33]. Conversely, for some, being able 
to maintain pre-cancer routines could help create feelings of normality [35]. Focusing on the 
present, taking one day at a time and accepting losses also helped participants to deal with 
challenges and regain wellness [10]. Building relationships with people and connections with 
nature was found useful for some patients [33] 
6. Facing mortality  
6.1 Having to face one’s mortality  
Hearing news of recurrence brought to the forefront thoughts of their mortality. Facing death 
and making preparations was acknowledged as emotionally challenging and required time to 
work through [25 26]. Participants faced the paradox of wanting to know the implications of 
the diagnosis, while also preferring information to be given gradually in order to allow them 
to prepare to face their mortality [36]. Undertaking practical preparations and relinquishing 
roles was part of this process [26] with some realisation that this process is never complete 
[25]. Patients grieved the loss of their envisaged future and the prospect of their early death 
[9 10 32]. Experiencing symptoms triggered thoughts of death, while periods of recovery 
heightened their desire for prolonged life [25]. 
6.2 Changing perspectives on life as a result of facing mortality  
Diagnosis of recurrence provided an opportunity to evaluate previous life choices and, for a 
number of participants, led to a change in priorities [9 27 31], where previous concerns lost 
their importance [27]. Heightened appreciation of life and their remaining time was common 
among participants [9 10 25 26 32 33]. Engaging with their mortality enhanced self-
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awareness of both personal strengths as well as weaknesses [10]. Facing one’s mortality and 
finalising preparations for death, allowed some to live in the present [26].  
Conclusions  
Stage 7, expressing the synthesis, is the last of Noblit and Hare’s stages and concerns the 
dissemination of the findings to maximise their impact.  We have interpreted this from the 
perspective of applied health research as identifying the implications for health care practice. 
This meta-ethnography has demonstrated the complexity of the issues patients face when 
diagnosed with a recurrence. It fills an important gap in the literature by bringing together a 
wide range of qualitative studies of the experiences of patients at this difficult stage. It builds 
on an earlier narrative review of the psycho-social impact of recurrent cancer, which included 
both qualitative and quantitative studies up to 2007. In addition, the interpretative nature of 
the current qualitative synthesis, has allowed us to develop a new conceptual understanding 
of the experiences of patients with a recurrence [18].  
The diagnosis of cancer recurrence evoked a range of emotions including fear, anger, shame 
and guilt. Quantitative studies have questioned whether the initial cancer diagnosis or the 
diagnosis of a recurrence is more distressing and have assessed levels of anxiety and 
depression at each stage [38] whereas the evidence presented in this synthesis adds to our 
understanding of the complexity of the emotions experienced by patients. We found no 
evidence that recurrence is either more or less demanding emotionally than initial diagnosis 
and suggest a more useful focus may be on describing the nature of their distress, rather than 
on measuring its intensity.   
Studies also highlighted that regardless of their vigilance and knowledge that cancer can 
return, patients still found the news of recurrence unexpected and deeply distressing.  In 
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addition, several studies in our review found that patients initially attributed symptoms of 
recurrence to non-cancer causes [9 28 30].  A recent review of patients views of follow up 
suggested that patients see the aim of follow up appointments as providing reassurance, and  
that they lacked information on the effectiveness of follow up tests [39]. We would agree 
with the authors of this review that it is important for patients to be provided with easy to 
understand information regarding the aims of follow up, and to be prepared for the possibility 
of recurrence and what signs to look out for.  It is a difficult balance for health professionals 
to achieve between offering hope and preparing for the worst – patient preferences are likely 
to vary in this regard and skilful communication is required.  
 
The perception of recurrence as shattering hopes for cure and bringing a real threat of 
mortality,  has also been found in reviews of the experiences of patients with recurrent breast 
cancer [12 13]. In our review, these concerns seem to be magnified for those not eligible for 
surgery, with patients viewing surgery as the only possible route to a cure. Health care 
professionals could play an important role in helping patients to adjust to a changing situation 
by balancing hope with acceptance that a cure may not be possible. 
In the context of the changing meaning of a diagnosis, information about the illness and its 
prognosis was important to patients, with most studies finding that patients wanted more 
information specific to recurrence. They valued information from both their clinical team and 
other cancer patients at the same stage of illness, but sometimes this was lacking. Previous 
qualitative studies have demonstrated that compared with mixed-stage groups, stage-specific 
support groups can be more helpful for patients [40]. It could be useful for health care 
professionals to provide them with opportunities to meet other cancer patients at stage of 
recurrence or signpost them to charities, which could complement support from health care 
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professionals. Equally, providing information in a sensitive manner was also important as it 
facilitated positive experiences of care.  Thorne and colleagues [41] point out that 
communication can facilitate or hinder human connection and it is important that health care 
professionals are sensitive to patients at this vulnerable stage.  
In order to deal with uncertainty, patients tried to regain control by taking care of themselves, 
using complementary therapies or seeking second opinions. Previous studies have also 
recognised these as facilitating hope and a sense of empowerment [42 43]. Leaving a legacy, 
giving up stressful activities and focusing in the present also helped patients to restore their 
emotional well-being. It is important that health care professionals provide support to patients 
to help them access self-management strategies such as these, as appropriate to their own 
individual circumstances. 
Recurrence clearly had an impact not only on individuals but also on families and the 
patients’ wider social context. Patients valued having an opportunity to talk about their 
concerns, but this was often limited with both family and the clinical team. Closer 
collaboration between secondary care and palliative care may be needed to facilitate these 
conversations. This is expressed in the vision of NCSI for Active and Advanced Disease 
which focuses specifically on the early introduction of palliative care services to facilitate 
discussions in a timely manner [44]. Equally, support is needed to assist family members to 
help patients face the possibility of death.   
A strength of this meta-ethnography is that, in contrast to previous reviews [12 13], it has 
included studies of a number of different types of cancer. It has thus been possible to identify 
the challenges across a range of cancer types as well as those relevant to specific patient 
groups. A limitation, however, is the diversity of time frames used in the studies that were 
included. A few studies conducted interviews shortly following diagnosis of a recurrence (up 
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to two months), some in an intermediate period (5-10 months), while some were based on 
largely retrospective data gathered up to 6 years following news of the recurrence. The time 
between initial diagnosis and the recurrence of cancer also varied widely which may also 
have affected their experience of the recurrence their cancer [11]. 
The majority of studies in our review focused on breast and ovarian cancer, and further 
studies are needed to explore any specific issues regarding the impact of cancer recurrence in 
other cancer groups, especially bowel cancer given its high incidence and recurrence rates. 
This meta-ethnography has identified, reviewed and synthesised the qualitative studies of 
patients’ experience of a recurrence of cancer published in the last 20 years.  Six third order 
constructs were developed to capture features common to the experience of recurrence across 
a range of cancer types. These constructs have provided the framework for discussing the 
diversity and complexity of patients’ experiences and for considering the implications for 
health care professionals. 
Conflict of interest: None 
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Table 1: Search terms                                       
1. (maximum variation or snowball).mp. 
2. (thematic$ adj3 analys$).mp. 
3. (participant* adj3 observ*).mp. 
4. (nonparticipant* adj3 observ*).mp. 
5. (non participant* adj3 observ$).mp. 
6. (structured categor* or unstructured categor*).mp. 
7. action research.mp. 
8. (audiorecord* or taperecord* or videorecord* or videotap*).mp. 
9. ((audio or tape or video*) adj5 record*).mp. 
10. ((audio* or video* or tape*) adj5 interview*).mp. 
11. (content analy* or field note* or fieldnote* or field record* or field stud*).mp. 
12. (qualitative* or ethno* or emic* or etic or emic or phenomenolog*).mp. 
13. (hermeneutic* or heidegger* or husserl* or colaizzi* or giorgi* or glaser or strauss).mp. 
14. (van kaam* or van manen or constant compar*).mp. 
15. (focus group* or grounded theory or narrative* or lived experience* or life 
experience*).mp. 
16. (theoretical sampl* or purposive sampl* or ricoeur or spiegelber* or merleau ponty).mp. 
17. IPA.mp. 
18. interview*.mp. 
19. biographical.mp. 
20. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 
18 or 19 
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21. adjustment.mp. 
22. perception.mp. 
23. "information need*".mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, tc, id, tm] 
24. "supportive need*".mp. 
25. "supportive care*".mp. 
26. experience*.mp. 
27. psycho-social.mp. 
28. psychosocial.mp. 
29. psycholog*.mp. 
30. social.mp. 
31. adaptation.mp. 
32. information*.mp. 
33. 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 
34. (cancer* or carcinoma* or malignan* or tumour or tumor or neoplasm*).mp. 
35. (secondar* or recur* or relapse* or metasta* or advanced).mp. 
36. 34 and 35 
37. 20 and 33 and 36 
38. limit 37 to English language 
39. limit 38 to humans 
40. remove duplicates from 39 
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Table 2: An example of the first and second-order extraction:   
Third order 
construct 
Paper Second-
order 
constructs 
Description of the 
second-order 
construct 
First order construct 
(quote from the 
participants) 
Fears of 
recurrence 
becoming 
a reality 
 
 
 
 
 
 
Fears of 
recurrence 
becoming 
a reality 
Mahon and 
Casperson 
[9] 
Diagnosis 
of 
recurrence 
Participants 
experienced a variety 
of symptoms and 
attributed them 
initially mainly to 
non-cancer causes. 
They described the 
emotional reactions 
of being 
overwhelmed and 
shocked even though 
being prepared for 
recurrence.  
 
 
I knew all along that it 
could come back but let 
me tell you, nothing could 
prepare you for it. Even 
though I knew it was 
happening. I got real 
lightheaded when doctor 
told me.  
Griffiths et 
al. [27] 
Emotional 
reactions  
Participants described 
the emotional impact 
of diagnosis 
including shock, 
devastation, 
emotional 
vulnerability and 
hopelessness. Also 
experienced intense 
feelings of shame, 
often related to 
feeling a burden on 
loved ones. 
 
 
 
I just felt numb. I was 
speechless.  
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Study and Dixon-
Woods et al. 
(2004) Coding 
(K=Key paper, 
SAT- 
satisfactory, FF- 
fatally flawed 
IRR -Irrelevant) 
Country 
setting 
Sample N (age, 
gender and 
cancer site: 
primary)  
Time since 
the initial 
diagnosis 
Length of time 
with diagnosis 
of recurrence 
Methods of data 
collection 
Methods of data 
analysis 
Aim 
Chunklestskul et 
al.  [26] 
K 
Canada  N= 5 women,  
44-72 years 
breast 
 
 
 
16-18 years 2-6 years Open –ended 
interviews on two 
occasions 
Phenomenological 
approach (not 
defined) 
To explore the lived 
experiences of women with 
metastatic breast cancer in 
preparation for their death  
Chunklestskul,et 
al. [25] 
K 
Canada N= 5 women, 
44-72 years  
breast 
 
16-18 years 2-6 years Open –ended 
interviews on two 
occasions 
Phenomenological 
approach (not 
defined) 
To examine enabling and 
impeding factors in death 
preparations  
Table 3: Studies descriptions 
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Coward and 
Wilkie [28] 
SAT 
USA N=20, 10 
women and 10 
men,  
26-73 years,  
breast, lung, 
bladder, 
prostate, kidney 
and thyroid 
1-13 years 1 month- 8 
years 
Semi-structured 
interviews  
Not specified To explore gender 
differences in experience of 
metastatic bone pain 
Dooks et al. [34] 
SAT 
 
Canada N=9, 1 woman 
and 8 men, 
60-75 years 
oral 
---------------- 6-12 months In depth interviews Interpretative 
descriptive approach 
by Sally Thorne 
(1997) 
To describe patients’ 
experience of reintegrating 
into community following 
surgery  
Ekwall et al. [7] 
SAT 
 
Sweden N=12 women,  
50-74 years 
ovarian 
 
1-5.7 years 
(Mean=2.8) 
5-10 months Interviews 
 
Phenomenological 
method (Giorgi and 
Giorgi, 2003) 
To explore experiences of 
women diagnosed with 
recurrent ovarian cancer and 
its impact on daily lives  
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Ekwall et al. [37] 
K 
Sweden N=12 women 
50-74 years 
(Median=57.5) 
ovarian 
1-5.7 years 5-10 months Interviews Qualitative content 
analysis: Grundheim 
and Lundman (2004) 
 
 
 
To explore what women 
with recurrent ovarian cancer 
perceive as important in their 
communication with the 
health care team   
Ekwall et al. [33] 
K 
 
Sweden N=4 women, 
46-69 years, 
ovarian 
6-10 years 3 years and 5 
years 
Open- ended 
interviews on two 
occasions (3 and 5 
years after 
recurrence) 
Phenomenological 
approach (Giorgi, 
2009) 
To explore the phenomenon 
of living with recurring 
ovarian cancer 
Elit et al. [8] 
SAT 
 
 
Canada N= 26 women, 
44-77 years 
ovarian,  
 
 
6-36 months 2 months Semi-structured 
interviews; 
 
 
 
Unspecified Content 
analysis;  
To explore treatment 
decision making process and 
experiences of women with 
recurrent ovarian cancer 
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Grifftths et al. 
[27] 
K 
UK N=9, 6 women 
and 3 men, 
63-85 years, 
oral 
 
---------------- 1-8 weeks Semi-structured 
interviews 
 
Grounded theory 
approach 
1)To investigate the 
psychosocial responses of 
patients with oral cancer 
recurrence; 2) To highlight 
the key psychological issues  
Howell, Fitch and 
Deane [30] 
 
SAT 
 
Canada N=12 out of 18 
women had 
recurrence; 
ovarian 
---------------- --------------- Semi-structured 
telephone 
interviews  
Not specified; coding 
scheme developed 
and used by all 
authors  
To explore the experience of 
women with ovarian cancer 
Maher and De 
Vries [29] 
 
SAT 
UK: 
London 
N=8, 5 women 
and 3 men,    
48-74 years, 
myeloma 
 
 
---------------- ---------------- Unstructured 
interviews  
Theoretical 
framework of 
Hermeneutic 
phenomenology; 
thematic content 
based on method of 
Colaizzi (1978)  
To explore how the 
experience of living with 
relapsed myeloma had 
affected the quality of life of 
patients 
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Mahon and  
Casperson [9] 
SAT 
USA N=20,  
26-72 years 
(Mean=54); 
type not 
specified 
8-94 months, 
(Mean=37 
months) 
30 days Unstructured and 
semi-structured 
interviews  
Not specified; 
Software used  
To describe the meaning of a 
recurrence of cancer to the 
patient and possible 
differences between  initial 
diagnosis and recurrence 
McCahill and 
Hamel- Bissell 
[35] 
SAT 
USA N=12; 5 women 
and 7 men, 
45-75 years,  
colorectal 
--------------- ---------------- In depth semi-
structured 
interviews 
Phenomenological 
approach;  Three step 
analysis using 
Colaizzi method 
(1978) 
To explore the lived 
experience of patients who 
experienced surgery for CRC 
liver metastasis  
Misra  et al. [31] 
SAT 
Canada N=15, 12 
women and 3 
men);  
thyroid 
1-21 years 
(Median= 5) 
11-79 months 
(Median=24) 
Semi-structured 
interviews  
 
 
Unspecified thematic 
analysis combined 
with grounded theory   
To explore the individual 
patient experiences relating 
to diagnosis and surgical 
treatment of loco-regional 
recurrence of thyroid cancer  
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Rose, Spencer 
and Rausch [45] 
IRR 
USA N=17, 
ovarian 
---------------- ------------------ Interviews Phenomenological 
method by Colaizzi 
(1978) 
To explore how patients with 
ovarian cancer recurrence 
experience humour  
        
Sarenmaln et al. 
[10] 
K 
Sweden N= 20 women, 
55-81 years;  
breast  
 
 
 
Median= 68 
weeks 
2 weeks- 24 
months 
In depth interviews 
 
Grounded theory: 
Glaser and Strauss 
1967 and Glaser 
(1978) 
To explore the main 
concerns of women with 
breast cancer recurrence and 
how they deal with breast 
cancer recurrence 
Step and Ray 
[36] 
K 
USA N=30 women, 
42-84 years, 
breast, lung, 
gynaecological 
and head and 
neck 
7.3 years ------------------ Interviews Thematic analysis 
(not specified) 
To explore patients’ 
experience of 
communication at time of 
initial diagnosis and 
recurrence  
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Vilhauler [32] 
SAT 
USA N=14 women;  
Mean age: 51.6 
years , breast 
 
---------------- Mean =25.8 
months 
Telephone 
interviews  
Content analysis  To investigate the 
experiences of women with 
metastatic breast cancer  
 
 
 
